Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Much Will The Liver Cirrhosis Market Be Worth By 2029?

The market size for liver cirrhosis has been experiencing substantial growth in the past years. Rising from $1.86 billion in 2024 to $1.99 billion in 2025 with a compound annual growth rate (CAGR) of 7.0%. Factors contributing to this growth during the historical period include an increased occurrence of liver diseases, elevated alcohol intake, an aging demographic, higher spending on healthcare, and amplified governmental initiatives.

Expectations are high for a significant surge in the liver cirrhosis market over the coming years. Predicted to reach a worth of $2.68 billion by 2029 with a compound annual growth rate (CAGR) of 7.7%, this growth during the forecast period can be linked to multiple factors. These include an increase in hepatitis infections, economic development, rapid urbanization, shifts in lifestyle, and a boom in medical tourism. Additionally, the forecast period anticipates major changes such as enhancements in diagnostic technology, innovative advances in technology, collaborative efforts and partnerships, the application of artificial intelligence, and the inclusion of comprehensive therapy methods.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22040&type=smp

What Market Forces Are Contributing To The Growth Of The Liver Cirrhosis Market?

The liver cirrhosis market is projected to expand due to rising alcohol intake. The term ‘alcohol consumption’ denotes the habitual ingestion of alcoholic beverages, evaluated on the basis of volume and frequency. The escalating habit of alcohol consumption is attributed to its perceived ability to relieve daily stress, facilitate social bonding at events, and augment relaxation periods. Furthermore, the growing promotion and accessibility of alcohol in different environments also contribute to this surge. Treatment for liver cirrhosis in individuals excessively consuming alcohol is centered around limiting further liver damage through abstinence, medication and supportive care, coupled with addressing alcohol dependency via counseling and rehabilitation. For example, statistics from the National Drugs Library, an entity based in Ireland responsible for data compilation, showed that in 2022, the average alcohol consumption for those aged above 15 years escalated to 10.2 liters of pure alcohol per capita, indicating a 7.6% surge from 2021. Consequently, the escalating alcohol intake is fueling the growth of the liver cirrhosis market.

Which Segments Define The Structure Of The Liver Cirrhosis Market?

The liver cirrhosismarket covered in this report is segmented –

1) By Type: Alcoholic Cirrhosis; Atrophic Cirrhosis; Biliary Cirrhosis; Cardiac Cirrhosis; Cryptogenic Cirrhosis

2) By Treatment: Antibiotics; Immunosuppressants; Other Treatments

3) By End Users: Hospitals; Specialty Clinics; Ambulatory Surgical Centers; Academic And Research Institutes; Other End Users

Subsegments:

1) By Alcoholic Cirrhosis: Compensated Alcoholic Cirrhosis; Decompensated Alcoholic Cirrhosis; Alcoholic Steatohepatitis (ASH)-Associated Cirrhosis

2) By Atrophic Cirrhosis: Post-necrotic Atrophic Cirrhosis; Macronodular Atrophic Cirrhosis; Micronodular Atrophic Cirrhosis

3) By Biliary Cirrhosis: Primary Biliary Cirrhosis (PBC); Secondary Biliary Cirrhosis; Autoimmune Biliary Cirrhosis

4) By Cardiac Cirrhosis: Right Heart Failure-Induced Cirrhosis; Chronic Passive Congestion Cirrhosis; Ischemic Hepatitis Cirrhosis

5) By Cryptogenic Cirrhosis: Non-Alcoholic Steatohepatitis (NASH)-Associated Cirrhosis; Idiopathic Cirrhosis; Metabolic Syndrome-Associated Cirrhosis

Which Long-Term Trends Will Play A Crucial Role In The Liver Cirrhosis Market?

Leading companies in the liver cirrhosis market are advancing treatment options by developing active implantable medical devices aimed at improving patient outcomes and expanding therapeutic possibilities. These devices are electronically powered implants designed to monitor or enhance organ function inside the body. For instance, in December 2024, Belgium-based Sequana Medical NV received U.S. FDA approval for its alfapump system—the first active implantable device approved in the U.S. for managing recurrent or refractory ascites related to liver cirrhosis. This innovative technology provides a continuous, automated way to manage fluid by transferring excess abdominal fluid to the bladder, significantly reducing the need for invasive paracentesis procedures. The alfapump addresses a U.S. market of around 70,000 patients, representing a major improvement in patient quality of life.

Which Firms Are Making The Biggest Impact In The Liver Cirrhosis Market?

Major companies operating in the liver cirrhosis market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, Novartis AG, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Novo Nordisk A/S, Viatris Inc., Grifols Therapeutics LLC, Shionogi Inc., Galectin Therapeutics Inc., NGM Biopharmaceuticals Inc., Madrigal Pharmaceuticals Inc., Akero Therapeutics Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/liver-cirrhosis-global-market-report

Which Region Is Forecasted To Lead The Liver Cirrhosis Market In The Coming Years?

North America was the largest region in the liver cirrhosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the liver cirrhosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=22040&type=smp

Browse Through More Reports Similar to the Global Liver Cirrhosis Market 2025, By The Business Research Company

Liver Diseases Therapeutics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/liver-diseases-therapeutics-global-market-report

Liver Cancer Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/liver-cancer-diagnostics-global-market-report

Human Liver Model Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/human-liver-model-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model